Raymond James Trust N.A. Purchases 345 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Raymond James Trust N.A. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.6% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,007 shares of the medical equipment provider’s stock after buying an additional 345 shares during the quarter. Raymond James Trust N.A.’s holdings in Intuitive Surgical were worth $4,916,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Advisors Asset Management Inc. lifted its position in shares of Intuitive Surgical by 18.1% during the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock valued at $2,945,000 after acquiring an additional 1,129 shares during the period. Gamco Investors INC. ET AL lifted its position in Intuitive Surgical by 2.2% during the first quarter. Gamco Investors INC. ET AL now owns 11,414 shares of the medical equipment provider’s stock worth $4,555,000 after purchasing an additional 244 shares during the period. Steel Grove Capital Advisors LLC acquired a new stake in Intuitive Surgical during the first quarter worth about $223,000. Morse Asset Management Inc increased its holdings in Intuitive Surgical by 2.4% in the 1st quarter. Morse Asset Management Inc now owns 17,452 shares of the medical equipment provider’s stock valued at $6,965,000 after buying an additional 412 shares during the period. Finally, London & Capital Asset Management Ltd raised its position in shares of Intuitive Surgical by 3.0% in the 1st quarter. London & Capital Asset Management Ltd now owns 59,339 shares of the medical equipment provider’s stock valued at $23,682,000 after buying an additional 1,727 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at approximately $4,727,816.73. This trade represents a 2.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 50,935 shares of company stock valued at $26,305,169. Company insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several recent analyst reports. Robert W. Baird lifted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Citigroup raised their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Piper Sandler reissued an “overweight” rating and set a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $524.61.

Intuitive Surgical Trading Down 0.5 %

NASDAQ:ISRG opened at $547.87 on Friday. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $552.00. The stock has a market capitalization of $195.14 billion, a price-to-earnings ratio of 88.08, a PEG ratio of 5.41 and a beta of 1.39. The firm has a fifty day simple moving average of $504.73 and a two-hundred day simple moving average of $463.02.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Equities analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.